Fumonisin inhibition of ceramide synthase: A possible risk factor for human neural tube defects

Ronald T. Riley, Kenneth A. Voss, Marcy Speer, Victoria L. Stevens, Janee Gelineau-van Waes

Research output: Chapter in Book/Report/Conference proceedingChapter

6 Citations (Scopus)

Abstract

Fumonisins are carcinogenic mycotoxins that cause farm animal diseases. They commonly contaminate maize and are suspected, but not proven, to cause human disease. Their mode of action involves inhibition of the enzyme (ceramide synthase) that controls the formation of sphingolipids, important regulators of pathways involved in cell death and survival. Sphingolipids are needed for the proper function of receptors associated with lipid rafts (for example, the high affinity folate-binding protein). Fumonisin disruption of folate transport interferes with neural tube closure in animal models in vitro, and this effect is reduced by folate supplementation. In vivo studies in the LMBc mouse strain have shown that maternal fumonisin administration during pregnancy causes a dose-related increase in the frequency of neural tube defects (NTDs) in the embryos. Co-exposing the dams to folate or ganglioside GM1 is protective, suggesting that fumonisin alters sphingolipid-dependent lipid raft function. In addition, altered expression of cytokines, inducible nitric oxide synthase, elevated levels of sphinganine and sphinganine 1-phosphate and several genes involved in redox homeostasis are observed in affected embryos. NTDs are the second most common birth defect in humans. The etiology of human NTDs is complex. Increased risk has been associated with genetic predisposition, dietary exposure to environmental contaminants, and reduced intake of folate and other vitamins/nutrients. Human clinical and epidemiological studies show folate supplementation reduces the risk for NTDs. While there is no direct evidence for fumonisin as a cause of NTD in humans, the incidence of NTD is higher where maize consumption is high, and both fumonisin exposure and folate deficient diets are likely. Thus, it has been hypothesized that fumonisin inhibition of ceramide synthase is a risk factor for NTDs in humans with folate deficient diets who consume large quantities of low quality maize.

Original languageEnglish
Title of host publicationSphingolipid Biology
PublisherSpringer Japan
Pages345-361
Number of pages17
ISBN (Print)4431341986, 9784431341987
DOIs
StatePublished - 2006
Externally publishedYes

Fingerprint

Fumonisins
Neural Tube Defects
Folic Acid
Defects
Sphingolipids
Zea mays
Nutrition
Animals
Embryonic Structures
Diet
G(M1) Ganglioside
Lipids
Animal Diseases
Neural Tube
dihydroceramide desaturase
Mycotoxins
Domestic Animals
Environmental Exposure
Nitric Oxide Synthase Type II
Cell death

All Science Journal Classification (ASJC) codes

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Riley, R. T., Voss, K. A., Speer, M., Stevens, V. L., & Gelineau-van Waes, J. (2006). Fumonisin inhibition of ceramide synthase: A possible risk factor for human neural tube defects. In Sphingolipid Biology (pp. 345-361). Springer Japan. https://doi.org/10.1007/4-431-34200-1_28

Fumonisin inhibition of ceramide synthase : A possible risk factor for human neural tube defects. / Riley, Ronald T.; Voss, Kenneth A.; Speer, Marcy; Stevens, Victoria L.; Gelineau-van Waes, Janee.

Sphingolipid Biology. Springer Japan, 2006. p. 345-361.

Research output: Chapter in Book/Report/Conference proceedingChapter

Riley, Ronald T. ; Voss, Kenneth A. ; Speer, Marcy ; Stevens, Victoria L. ; Gelineau-van Waes, Janee. / Fumonisin inhibition of ceramide synthase : A possible risk factor for human neural tube defects. Sphingolipid Biology. Springer Japan, 2006. pp. 345-361
@inbook{b327ad42ad794cf3a65bb5a49bca84fb,
title = "Fumonisin inhibition of ceramide synthase: A possible risk factor for human neural tube defects",
abstract = "Fumonisins are carcinogenic mycotoxins that cause farm animal diseases. They commonly contaminate maize and are suspected, but not proven, to cause human disease. Their mode of action involves inhibition of the enzyme (ceramide synthase) that controls the formation of sphingolipids, important regulators of pathways involved in cell death and survival. Sphingolipids are needed for the proper function of receptors associated with lipid rafts (for example, the high affinity folate-binding protein). Fumonisin disruption of folate transport interferes with neural tube closure in animal models in vitro, and this effect is reduced by folate supplementation. In vivo studies in the LMBc mouse strain have shown that maternal fumonisin administration during pregnancy causes a dose-related increase in the frequency of neural tube defects (NTDs) in the embryos. Co-exposing the dams to folate or ganglioside GM1 is protective, suggesting that fumonisin alters sphingolipid-dependent lipid raft function. In addition, altered expression of cytokines, inducible nitric oxide synthase, elevated levels of sphinganine and sphinganine 1-phosphate and several genes involved in redox homeostasis are observed in affected embryos. NTDs are the second most common birth defect in humans. The etiology of human NTDs is complex. Increased risk has been associated with genetic predisposition, dietary exposure to environmental contaminants, and reduced intake of folate and other vitamins/nutrients. Human clinical and epidemiological studies show folate supplementation reduces the risk for NTDs. While there is no direct evidence for fumonisin as a cause of NTD in humans, the incidence of NTD is higher where maize consumption is high, and both fumonisin exposure and folate deficient diets are likely. Thus, it has been hypothesized that fumonisin inhibition of ceramide synthase is a risk factor for NTDs in humans with folate deficient diets who consume large quantities of low quality maize.",
author = "Riley, {Ronald T.} and Voss, {Kenneth A.} and Marcy Speer and Stevens, {Victoria L.} and {Gelineau-van Waes}, Janee",
year = "2006",
doi = "10.1007/4-431-34200-1_28",
language = "English",
isbn = "4431341986",
pages = "345--361",
booktitle = "Sphingolipid Biology",
publisher = "Springer Japan",
address = "Japan",

}

TY - CHAP

T1 - Fumonisin inhibition of ceramide synthase

T2 - A possible risk factor for human neural tube defects

AU - Riley, Ronald T.

AU - Voss, Kenneth A.

AU - Speer, Marcy

AU - Stevens, Victoria L.

AU - Gelineau-van Waes, Janee

PY - 2006

Y1 - 2006

N2 - Fumonisins are carcinogenic mycotoxins that cause farm animal diseases. They commonly contaminate maize and are suspected, but not proven, to cause human disease. Their mode of action involves inhibition of the enzyme (ceramide synthase) that controls the formation of sphingolipids, important regulators of pathways involved in cell death and survival. Sphingolipids are needed for the proper function of receptors associated with lipid rafts (for example, the high affinity folate-binding protein). Fumonisin disruption of folate transport interferes with neural tube closure in animal models in vitro, and this effect is reduced by folate supplementation. In vivo studies in the LMBc mouse strain have shown that maternal fumonisin administration during pregnancy causes a dose-related increase in the frequency of neural tube defects (NTDs) in the embryos. Co-exposing the dams to folate or ganglioside GM1 is protective, suggesting that fumonisin alters sphingolipid-dependent lipid raft function. In addition, altered expression of cytokines, inducible nitric oxide synthase, elevated levels of sphinganine and sphinganine 1-phosphate and several genes involved in redox homeostasis are observed in affected embryos. NTDs are the second most common birth defect in humans. The etiology of human NTDs is complex. Increased risk has been associated with genetic predisposition, dietary exposure to environmental contaminants, and reduced intake of folate and other vitamins/nutrients. Human clinical and epidemiological studies show folate supplementation reduces the risk for NTDs. While there is no direct evidence for fumonisin as a cause of NTD in humans, the incidence of NTD is higher where maize consumption is high, and both fumonisin exposure and folate deficient diets are likely. Thus, it has been hypothesized that fumonisin inhibition of ceramide synthase is a risk factor for NTDs in humans with folate deficient diets who consume large quantities of low quality maize.

AB - Fumonisins are carcinogenic mycotoxins that cause farm animal diseases. They commonly contaminate maize and are suspected, but not proven, to cause human disease. Their mode of action involves inhibition of the enzyme (ceramide synthase) that controls the formation of sphingolipids, important regulators of pathways involved in cell death and survival. Sphingolipids are needed for the proper function of receptors associated with lipid rafts (for example, the high affinity folate-binding protein). Fumonisin disruption of folate transport interferes with neural tube closure in animal models in vitro, and this effect is reduced by folate supplementation. In vivo studies in the LMBc mouse strain have shown that maternal fumonisin administration during pregnancy causes a dose-related increase in the frequency of neural tube defects (NTDs) in the embryos. Co-exposing the dams to folate or ganglioside GM1 is protective, suggesting that fumonisin alters sphingolipid-dependent lipid raft function. In addition, altered expression of cytokines, inducible nitric oxide synthase, elevated levels of sphinganine and sphinganine 1-phosphate and several genes involved in redox homeostasis are observed in affected embryos. NTDs are the second most common birth defect in humans. The etiology of human NTDs is complex. Increased risk has been associated with genetic predisposition, dietary exposure to environmental contaminants, and reduced intake of folate and other vitamins/nutrients. Human clinical and epidemiological studies show folate supplementation reduces the risk for NTDs. While there is no direct evidence for fumonisin as a cause of NTD in humans, the incidence of NTD is higher where maize consumption is high, and both fumonisin exposure and folate deficient diets are likely. Thus, it has been hypothesized that fumonisin inhibition of ceramide synthase is a risk factor for NTDs in humans with folate deficient diets who consume large quantities of low quality maize.

UR - http://www.scopus.com/inward/record.url?scp=64749084270&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=64749084270&partnerID=8YFLogxK

U2 - 10.1007/4-431-34200-1_28

DO - 10.1007/4-431-34200-1_28

M3 - Chapter

AN - SCOPUS:64749084270

SN - 4431341986

SN - 9784431341987

SP - 345

EP - 361

BT - Sphingolipid Biology

PB - Springer Japan

ER -